Navigation Links
Easier Treatment for Blood Clot

A pulmonary embolism is a fairly common condition that can be fatal. It is defined as an obstruction of a blood vessel in the lungs, usually due to a blood clot, //which blocks a coronary artery. While treatment is not always successful for a pulmonary embolism, a new study shows a new treatment is just as effective and easier to administer to patients than the current treatment.

According to the American Heart Association, about 600,000 Americans develop a pulmonary embolism annually; 60,000 die from one. The standard treatment for a pulmonary embolism is intravenous heparin requiring the patient to be monitored and hospitalized. Researchers conducted a study to see if a daily injection of the drug fondaparinux would be effective for patients with a pulmonary embolism.

The study included 2,213 patients who had a pulmonary embolism. The patients received either one of three doses of fondaparinux or a continuous intravenous infusion of heparin. Both of the drugs were given for five days. Researchers compared how the patients in each group did after three months and noted if they had a recurrent pulmonary embolism.

Researchers report only 42 of the 1,103 patients on fondaparinux had a recurrent problem compared to 56 of the 1,110 patients on the standard treatment. They also found major bleeding occurred in 1.3 percent of the patients on fondaparinux compared to 1.1 percent of the patients on heparin. The mortality rates after three months were similar in the two groups. About 15 percent of the patients on fondaparinux received the drug on an outpatient basis.

Study authors conclude treatment of pulmonary embolisms with fondaparinux is at least as effective and as safe as the standard treatment. They feel because of the simplicity in giving fondaparinux, it could become the first treatment of choice for many patients with a pulmonary embolism.
'"/>




Page: 1

Related medicine news :

1. Drug May Make Breathing Easier for Millions
2. Easier Dialysis for Kids
3. Easier Methods Required to Screen Insulin Resistance
4. Easier Methods Required to Screen Insulin Resistance
5. Adopting Easier Methods To Screen Insulin Resistance
6. Easier Tests To Detect Tuberculosis
7. Self Hypnotic Relaxation Makes Breast Biopsy Easier and Less Painful
8. Asthmatic Children Still Not Breathing Easier, Study Says
9. Advances in Treatment of Cataracts
10. Recommendations for Treatment of Blood Pressue
11. Treatment for Menieres disease
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Easier Treatment for Blood Clot

(Date:10/10/2008)... BEDFORD, Mass., Oct. 10 /PRNewswire-FirstCall/...loper, manufacturer and supplier of premium,diagno...ts dedicated to,serving the healthcare needs of wo...uarter and fiscal 2008 operating results on Tuesda...ction with the release, management will,host a con...
(Date:10/10/2008)... PARK CITY, Utah, Oct. 10 /PRNewswire/ -- NuVie... management of Trace Life Sciences Inc.,(Trace), i...cyclotron,production facilities in Denton, Texas. ... Indium-111, Iodine-123 and Thallium-201 used in,m... NuView Chairman and,CEO, stated that "We are conf...
(Date:10/10/2008)... Coach Holly Warlick Teams Up with Legal and Me...rst-Ever Cancer and Careers Seminar in,Knoxville, ...gnition of National,Breast Cancer Awareness Month,... have joined forces with YWCA Knoxville, The Welln...ocate Holly Warlick, University of Tennessee,women...
(Date:10/10/2008)... The Healthcare Technolog...Care , Exton, PA (PRWEB) ...Valley Chapters of the national Healthcare Informa...ned forces to bring regional health information te...onal conference entitled The Healthcare Technology...
Breaking Medicine News(10 mins):Health News:Hologic, Inc. To Release Fourth Quarter and Fiscal 2008 Operating Results on Tuesday, November 11, 2008 2Health News:Local Experts Help Women Living and Working with Cancer Even the Score 2Health News:Local Experts Help Women Living and Working with Cancer Even the Score 3Health News:Local Experts Help Women Living and Working with Cancer Even the Score 4Health News:HIMSS New Jersey and Delaware Valley Chapters Sponsor Regional Conference 2
...s due to medical errors are on the rise. Medical e...given on the drug labels. Food and Drug Administra...t section //thereby making it easy for the doctors...re they could assess a drug as completely safe for...
...ly suffering from terminal cancer. The zoo officia... as comfortable and pleasant as possible. // A lar...k of the animal, which has been developing rapidly...rformed to remove the node, the animal is not expe...
...sia and many countries fear that it might one day ...e been done to develop a new dug to combat the dis...institute have found that Sambucol (an extract fro...n reducing the spread of virus in the cells. <...
...samples and their personal information about their...ation to one of the two biggest medical research p... American Project. The American project is still i...tarted very soon. The Project would be collecting ...
Other Medicine News:Health News:New Rule Results In The Complete Makeover In The Field Of Drug Advertising 2
(Date:10/9/2008)...ranslational Science Institute, Navigenics, Affyme...tudy, SAN DIEGO, Oct. 9 /- A consort...s have joined forces in a first-of-its-kind,resear...al genetic testing,on people who choose to receive...for developing certain diseases., Sponsored by Sc...
(Date:10/8/2008)...s May Someday Inform Treatments for Spinal Cord, O...wswire-USNewswire/ -- A protein that enables,nerve...role in controlling,the developing nervous system....ections to form among nerve cells may provide a ba...r injuries to their nervous system,including spin...
(Date:10/8/2008)...cal program to evaluate TAXUS(R) Element(TM) Plati..., NATICK, Mass., Oct. 8 /-... announced that it has completed enrollment in,the... third-generation,TAXUS(R) Element(TM) paclitaxel-...am has enrolled nearly 1,500 patients at 100 U.S. ...
(Date:10/7/2008)..., Oct. 7 /- Prometheus Laboratories I...ounced findings from its,development of PROMETHEUS...for irritable bowel syndrome (IBS). The findings s... particular biomarkers in blood samples,between IB...e biomarkers,combined with a proprietary algorith...
Breaking Medicine Technology:Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 2Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 3Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 4Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 5Protein Shown to Play a Key Role in Normal Development of Nervous System 2Protein Shown to Play a Key Role in Normal Development of Nervous System 3Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 2Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 3Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 4Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 2Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 3How to treat gastroesophageal adenocarcinom patients 3F 26537 1How to treat gastroesophageal adenocarcinom patients 3F 26537 2Does probiotic intervention induce the serum global lipid profile change 3F 26535 1Does probiotic intervention induce the serum global lipid profile change 3F 26535 2Novel anti cancer mechanism found in long lived rodents 4942 1Novel anti cancer mechanism found in long lived rodents 4942 2Pharmasset to Present at the UBS Global Life Sciences Conference on Wednesday September 24th 3090 1Pharmasset to Present at the UBS Global Life Sciences Conference on Wednesday September 24th 3090 2
...Data Presented at Leading Influenza Conference, HI... Previously,undisclosed pre-clinical data showing ... against all strains of influenza, including,pande...t the 2007,Options for the Control of Influenza VI...re-clinical results, which will be published in th...
... LUND, Sweden, June 18, 2007-Active Biotech (OMX N...he 57-57 project at the 8th,World Congress on Infl...lammation2007.dk/">www.inflammation2007.dk ) held,...en the further clinical development of,57-57 for t...duce,the use of steroids. Phase II clinical trials...
Other Medicine Technology:New Flu Vaccine From PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 2New Flu Vaccine From PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 3New Flu Vaccine From PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 4Active Biotech presents new pre-clinical data for the 57-57 project,at the 8th World Congress on Inflammation 2
A Color-Enhanced Slide Agglutination Test for the Rapid Qualitative and Semi-Quantitative Detection of Rheumatoid Factor in Serum.
Hemagglutination slide test for the qualitative and quantitative detection of infectious mononucleosis heterophile antibodies in serum or plasma.
Color-enhanced hemagglutination slide test for the rapid qualitative and semi-quantitative detection of infectious mononucleosis heterophile antibodies in serum or plasma.
... Inverness Medical Professional Diagnostics is a l... an extensive IFA and DFA test menu that includes ...and STDs as well as miscellaneous conjugates and c...wide assortment of substrates and kit sizes to cho...
Medicine Products: